Literature DB >> 2369813

Economic impact of oral ciprofloxacin following standard intravenous therapy.

R M Fliegelman1, P M Mattingly, C L Dempsey, S J Sokalski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2369813     DOI： 10.1016/0732-8893(90)90107-7

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


× No keyword cloud information.
  9 in total

1.  Sequential antimicrobial therapy: a realistic approach to cost containment?

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

Review 2.  Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors:  J A Balfour; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

3.  Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones.

Authors:  K M Jensen; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

Review 4.  Cost-effective treatment of lower respiratory tract infections.

Authors:  J C Garrelts; A M Herrington
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

5.  The new fluoroquinolones: A critical review.

Authors:  G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal:  Can J Infect Dis       Date:  1999-05

6.  Oral ciprofloxacin vs intravenous therapy with nonquinolone agents. A study of 291 infections.

Authors:  V Lorian; K Pavletich
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 7.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

8.  Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns.

Authors:  Ornella Conort; Steven Gabardi; Marie-Pauline Didier; Georges Hazebroucq; Alain Cariou
Journal:  Pharm World Sci       Date:  2002-04

Review 9.  Quinolone antibacterials. An update of their pharmacology and therapeutic use.

Authors:  N von Rosenstiel; D Adam
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.